Clinical trial
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
NCT00494559 · Korea University Anam Hospital, Other · Completed
Key facts
| NCT number | NCT00494559 |
|---|---|
| Title | The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers |
| Official title | Phase 4 Study of Pioglitazone on Neointima Volume and Inflammatory Markers in Diabetic Patients |
| Lead sponsor | Korea University Anam Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Coronary Artery Stenosis |
| Intervention type | Drug |
| Interventions | Pioglitazone, Placebo |
| Enrollment | 240 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2015 |
| First posted | Jun 29, 2007 |
| Last update posted | Feb 25, 2016 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: